Akesis appoints President
'A step toward establishing a standard for the industry'
Former Executive VP of research and innovation at Elekta appointed Chief Technology Officer of the company
After 10 years of clinical trials, focused ultrasound is FDA approved for prostate
Produced more false positives, less accurate in cases with multiple diseases
Q&A with Karol Fajardo Mariño, director of international business at Corferias
Driven by sales growth at Varian and in Siemens Healtineers' medical imaging unit
The agreement also provides Gilead with a newly approved, novel breast cancer therapy
Five tumors treated in less than 20 minutes
New protocols aim to combine CyberKnife with chemotherapy
Comparing options for stereotactic radiosurgery
Q&A with Eugenia Brandt, ACR's director of Senior Government Affairs
Subject to regulatory approvals and other customary closing conditions, the companies expect to close the transaction by the first quarter 2007.
Tulsa Cancer Institute's "behind-the-scenes" decision-making.
B. Braun of America Inc. appoints CEO
